392 related articles for article (PubMed ID: 18982834)
1. Big pharma and health care: unsolvable conflict of interests between private enterprise and public health.
Brezis M
Isr J Psychiatry Relat Sci; 2008; 45(2):83-9; discussion 90-4. PubMed ID: 18982834
[TBL] [Abstract][Full Text] [Related]
2. Guidelines, editors, pharma and the biological paradigm shift.
Singh AR; Singh SA
Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
[TBL] [Abstract][Full Text] [Related]
3. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
4. Taking behavioralism seriously: some evidence of market manipulation.
Hanson JD; Kysar DA
Harv Law Rev; 1999 May; 112(7):1420-572. PubMed ID: 10558427
[TBL] [Abstract][Full Text] [Related]
5. The politics of lead toxicology and the devastating consequences for children.
Rosner D; Markowitz G
Am J Ind Med; 2007 Oct; 50(10):740-56. PubMed ID: 17486583
[TBL] [Abstract][Full Text] [Related]
6. Private enterprise and public good: ethical issues in the funding of clinical research.
Williams AH; Rowell M
Ann R Coll Physicians Surg Can; 1999 Jun; 32(4):227-31. PubMed ID: 12385289
[TBL] [Abstract][Full Text] [Related]
7. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
8. Who is buying bioethics research?
Sharp RR; Scott AL; Landy DC; Kicklighter LA
Am J Bioeth; 2008 Aug; 8(8):54-8; discussion W1-2. PubMed ID: 18802867
[TBL] [Abstract][Full Text] [Related]
9. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy.
Mintzes B; Barer M; Lexchin J; Bassett KL
Res Social Adm Pharm; 2005 Jun; 1(2):310-30. PubMed ID: 17138480
[TBL] [Abstract][Full Text] [Related]
10. Vested interests in addiction research and policy poisonous partnerships: health sector buy-in to arrangements with government and addictive consumption industries.
Adams PJ; Buetow S; Rossen F
Addiction; 2010 Apr; 105(4):585-90. PubMed ID: 20403010
[TBL] [Abstract][Full Text] [Related]
11. Alcohol research and the alcoholic beverage industry: issues, concerns and conflicts of interest.
Babor TF
Addiction; 2009 Feb; 104 Suppl 1():34-47. PubMed ID: 19133913
[TBL] [Abstract][Full Text] [Related]
12. The economics of pediatric formulation development for off-patent drugs.
Milne CP; Bruss JB
Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
[TBL] [Abstract][Full Text] [Related]
13. Funding medical and health-related research in the public interest.
Baird PA
CMAJ; 1996 Aug; 155(3):299-301. PubMed ID: 8705910
[TBL] [Abstract][Full Text] [Related]
14. Shifting sands: assessing the balance between public, private not-for-profit and private for-profit physical therapy delivery in Ontario, Canada.
Landry MD; Williams AP; Verrier MC; Holyoke P; Zakus D; Deber RB
Physiother Res Int; 2008 Sep; 13(3):189-99. PubMed ID: 18613287
[TBL] [Abstract][Full Text] [Related]
15. [The development of the public health system between an increasing market orientation (commercialisation) and social responsibility].
Trabert G
Zentralbl Chir; 2008 Feb; 133(1):39-45. PubMed ID: 18278701
[TBL] [Abstract][Full Text] [Related]
16. The distribution of biomedical research resources and international justice.
Resnik DB
Dev World Bioeth; 2004 May; 4(1):42-57. PubMed ID: 15086373
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical industry agenda setting in mental health policies.
Gosden R; Beder S
Ethical Hum Sci Serv; 2001; 3(3):147-59. PubMed ID: 15278977
[TBL] [Abstract][Full Text] [Related]
18. Monitoring the tobacco use epidemic IV. The vector: Tobacco industry data sources and recommendations for research and evaluation.
Cruz TB
Prev Med; 2009 Jan; 48(1 Suppl):S24-34. PubMed ID: 18976685
[TBL] [Abstract][Full Text] [Related]
19. New strategies to improve food marketing to children.
Dietz WH
Health Aff (Millwood); 2013 Sep; 32(9):1652-8. PubMed ID: 24019372
[TBL] [Abstract][Full Text] [Related]
20. Nurse practitioners' perceptions and participation in pharmaceutical marketing.
Crigger N; Barnes K; Junko A; Rahal S; Sheek C
J Adv Nurs; 2009 Mar; 65(3):525-33. PubMed ID: 19222650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
